« Back to Record
Felip, E., Smit, E. F., Molina-Vila, M. A., Dafni, U., Massuti, B., Berghmans, T., de Marinis, F., Passiglia, F., Dingemans, A.-M. C., Cobo, M., Viteri, S., Britschgi, C., Cuffe, S., Provencio, M., Merkelbach-Bruse, S., Andriakopoulou, C., Kammler, R., Ruepp, B., Roschitzki-Voser, H., Peters, S., Wolf, J., Stahel, R. A. R., & ETOP 12-17 ALERT-lung Collaborators, (2022). Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial. Lung cancer, 172, 94-99. doi:10.1016/j.lungcan.2022.08.008
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/348934



